MEDIRAB IT is a fixed dose combination of Rabeprazole and Itopride. Rabeprazole is a proton pump inhibitor that reduces the production of stomach acid, providing relief from acid-related disorders such as acid reflux and gastroesophageal reflux disease (GERD). Itopride is a prokinetic agent that enhances gastrointestinal motility and helps in relieving symptoms like bloating, stomach discomfort, and nausea. Combining these two medications provides effective management of acid-related disorders along with improvements in digestion and gastrointestinal function.  

• Management of gastroesophageal reflux disease (GERD)
• Treatment of acid reflux
• Relief from symptoms like heartburn, stomach discomfort, and bloating
• Improvement of gastrointestinal motility and digestion

• Headache
• Diarrhea
• Nausea
• Rash
• Abdominal pain

Take MEDIRAB IT orally as directed by your doctor. Swallow the tablet whole, do not chew or crush it. Follow the prescribed dosage and duration of treatment.

• Pregnancy - Limited data is available regarding the safety of MEDIRAB IT during pregnancy. It is advised to consult your doctor before taking this medicine.
• Alcohol - It is advisable to avoid or limit the consumption of alcohol while taking this medicine as it may increase the risk of stomach-related side effects.
• Old Age - No specific precautions need to be taken while using MEDIRAB IT in the elderly population. However, it is advised to consult a doctor for proper evaluation and dosage adjustment.
• Breast Feeding - Limited data is available regarding the safety of MEDIRAB IT during breastfeeding. It is advised to consult your doctor before taking this medicine.
• Children - MEDIRAB IT is not recommended for use in children. Safety and efficacy in pediatric patients have not been established.

• Store at room temperature (20-25°C) -
• Protect from moisture and light -

• Drug-Drug - There are no known significant drug-drug interactions with MEDIRAB IT . However, it is always advisable to inform your doctor about all the medications you are taking, including over-the-counter drugs and herbal supplements.
• Drug-Food - There are no known significant drug-food interactions with MEDIRAB IT .
• Drug-Disease - MEDIRAB IT should be used with caution in patients with liver or kidney diseases. Consult your doctor for appropriate dosage adjustments.

• Q. Can I take MEDIRAB IT on an empty stomach?
  It is generally recommended to take MEDIRAB IT before meals to enhance its effectiveness. However, follow the instructions provided by your doctor for the best results.
• Q. Can I stop taking MEDIRAB IT once my symptoms improve?
  It is important to complete the prescribed course of treatment even if your symptoms improve. Discontinuing the medication prematurely may lead to a relapse of symptoms.
• Q. What should I do if I miss a dose of MEDIRAB IT ?
  If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for the missed one.
• Q. Can MEDIRAB IT be used for long-term treatment?
  The duration of treatment with MEDIRAB IT will be determined by your doctor based on your condition and response to treatment. Follow your doctor's instructions regarding the duration of therapy.
• Q. What should I do if I experience severe side effects while taking MEDIRAB IT ?
  If you experience severe or persistent side effects while taking MEDIRAB IT , consult your doctor immediately. They can evaluate your condition and provide appropriate medical guidance.